| Table 2. Information on national evaluations providing data to the Interbull | |||||
| routine evaluation for milk somatic cells, as provided by participating countries | |||||
| proof | |||||
| Country | Breed(s) | h2 | model | unit* | expression** |
| Canada | AYS | .25 | AM TD | SCS(2) | TA |
| BSW | .26 | -"- | -"- | -"- | |
| GUE | .33 | -"- | -"- | -"- | |
| HOL | .29 | -"- | -"- | -"- | |
| JER | .26 | -"- | -"- | -"- | |
| Denmark | AYS HOL JER | .11 | SM MT | SCC | TA |
| Estonia | HOL | .12 | AM TD | SCS(2) | RBV(-) |
| Finland | AYS HOL | .15 | AM | SCS(e) | RBV(-) |
| France | BSW HOL | .15 | AM | SCS(2) | RBV(-) |
| Germany | HOL AYS | .20 | AM TD | SCS(2) | BV |
| Israel | HOL | .10 | AM | SCS(2) | TA |
| Italy | HOL | .08 | AM TD | SCS(2) | RBV(-) |
| Netherlands | BSW HOL JER | .15 | AM | SCS(2) | RTA(-) |
| Sweden | AYS HOL | .08 | SM | SCC(10) | RBV(-) |
| Switzerland | HOL | .31 | AM TD | SCS(2) | BV |
| United Kingdom | AYS GUE HOL JER | .11 | AM | SCC(e) | TA |
| United States | AYS BSW GUE HOL JER | .10 | AM | SCS(2) | TA |
| *log-base used indicated within parenthesis | |||||
| **reversed scale, i.e. high values are desirable, indicated within parenthesis | |||||